secwatch.observer — SEC 8-K summary
======================================

Issuer:     InMed Pharmaceuticals Inc. (INM)
CIK:        0001728328
Form:       8-K
Filed at:   2026-06-10T10:01:19+00:00
Accession:  0001062993-26-003132
Event type: regulatory
Sentiment:  positive
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

InMed regains Nasdaq minimum bid price compliance; deficiency closed
--------------------------------------------------------------------

- Received Nasdaq notice on June 3, 2026 that bid price was at or above $1.00 for 10 consecutive business days (May 19–June 2).
- Previously notified of deficiency on March 27, 2026 for bid price below $1.00 for 30 consecutive days.
- Nasdaq has closed the matter; Company remains listed on the Nasdaq Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1728328/000106299326003132/0001062993-26-003132-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1728328/000106299326003132/form8k.htm
  HTML page:      https://secwatch.observer/filing/0001062993-26-003132

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer